Susquehanna Fundamental Investments’s Cohen & Steers CNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$974K Buy
15,579
+9,369
+151% +$611K 0.04% 294
2025
Q4
$390K Buy
+6,210
New +$404K 0.01% 455
2022
Q1
Sell
-4,859
Closed -$450K 1557
2021
Q4
$450K Hold
4,859
0.01% 955
2021
Q3
$407K Sell
4,859
-900
-16% -$76.3K 0.01% 1295
2021
Q2
$473K Sell
5,759
-10,194
-64% -$735K 0.01% 1193
2021
Q1
$1.04M Buy
15,953
+10,750
+207% +$735K 0.02% 872
2020
Q4
$387K Sell
5,203
-9,339
-64% -$616K 0.01% 1185
2020
Q3
$811K Buy
14,542
+4,742
+48% +$293K 0.02% 716
2020
Q2
$667K Buy
+9,800
New +$591K 0.03% 536
2018
Q4
Sell
-16,049
Closed -$652K 329
2018
Q3
$652K Hold
16,049
0.11% 211
2018
Q2
$669K Buy
+16,049
New +$645K 0.1% 239

Other funds holding CNS

Susquehanna Fundamental Investments's CNS Position: Q1 2026 in Review

Susquehanna Fundamental Investments increased its Cohen & Steers (CNS) stake by 151% in Q1 2026, buying an estimated $611K and bringing the position to 15,579 shares worth $974K. The position accounts for 0.04% of the portfolio, ranked #294.

Susquehanna Fundamental Investments first reported a position in CNS in Q2 2018 and has held it in 11 quarters since. The position peaked at $1.04M in Q1 2021. 295 funds tracked by Wall St. Rank hold CNS as of Q1 2026.

  • Susquehanna Fundamental Investments held 15,579 shares of Cohen & Steers worth $974K as of Q1 2026.
  • Susquehanna Fundamental Investments bought 9,369 Cohen & Steers shares in Q1 2026, an estimated $611K.
  • Cohen & Steers made up 0.04% of Susquehanna Fundamental Investments's portfolio in Q1 2026, its #294 holding.
  • Susquehanna Fundamental Investments first reported a position in Cohen & Steers in Q2 2018 and has held it in 11 quarters since.
  • Susquehanna Fundamental Investments's Cohen & Steers position peaked at $1.04M in Q1 2021.
  • 295 funds tracked by Wall St. Rank held Cohen & Steers as of Q1 2026.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2026, filed 15 May 2026.